Cornerstone Capital Management Holdings’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-19,798
| Closed | -$192K | – | 1376 |
|
|
2017
Q2 | $192K | Buy |
19,798
+5,031
| +34% | +$48.8K | ﹤0.01% | 1150 |
|
|
2017
Q1 | $357K | Buy |
+14,767
| New | +$357K | ﹤0.01% | 1101 |
|
|
2016
Q1 | – | Sell |
-178
| Closed | -$11K | – | 1623 |
|
|
2015
Q4 | $11K | Sell |
178
-152
| -46% | -$9.39K | ﹤0.01% | 1424 |
|
|
2015
Q3 | $22K | Sell |
330
-788
| -70% | -$52.5K | ﹤0.01% | 1454 |
|
|
2015
Q2 | $109K | Buy |
1,118
+343
| +44% | +$33.4K | ﹤0.01% | 1288 |
|
|
2015
Q1 | $72K | Buy |
775
+635
| +454% | +$59K | ﹤0.01% | 1295 |
|
|
2014
Q4 | $12K | Buy |
+140
| New | +$12K | ﹤0.01% | 1241 |
|